TCF7L2 is a downstream transcription factor in the canonical Wnt/β-catenin pathway, and it has been shown to be involved in insulin synthesis, vascular cell proliferation, inflammation, and plaque formation, all of which are key processes in atherosclerosis 39,58. Here, INS is linked to atherosclerosis.